autolytimycin

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 05/07/2010 - "Both reblastatin (1) and autolytimycin (2) were shown to bind the heat shock protein 90 with enhanced binding activity (approximately 25 nM) than 17-allylamino-17-demethoxygeldanamycin (17-AAG, 4), a geldanamycin (3) derivative currently under evaluation for treatment of cancer (approximately 100 nM)." 06/20/2017 - "Streptomyces autolyticus CGMCC 0516 produces the anti-tumor benzoquinone ansamycins geldanamycin, autolytimycin, and reblastatin and the 16-membered macrodiolide elaiophylin. "
2.	Colorectal Neoplasms (Colorectal Cancer) 09/01/2022 - "Both autolytimycin and seco-geldanamycin A showed potent activity against the proliferation of glioma, lung cancer, colorectal cancer and breast cancer cells. "
3.	Lung Neoplasms (Lung Cancer) 09/01/2022 - "Both autolytimycin and seco-geldanamycin A showed potent activity against the proliferation of glioma, lung cancer, colorectal cancer and breast cancer cells. "
4.	Glioma (Gliomas) 09/01/2022 - "Autolytimycin blocked cell cycle of glioma cells and seco-geldanamycin A induced apoptosis of glioma cells." 09/01/2022 - "Both autolytimycin and seco-geldanamycin A showed potent activity against the proliferation of glioma, lung cancer, colorectal cancer and breast cancer cells. "
5.	Breast Neoplasms (Breast Cancer) 09/01/2022 - "Both autolytimycin and seco-geldanamycin A showed potent activity against the proliferation of glioma, lung cancer, colorectal cancer and breast cancer cells. "

1.	geldanamycin
2.	reblastatin
3.	Macrocyclic Lactams
4.	Heat-Shock Proteins (Heat-Shock Protein)
5.	tanespimycin (17AAG)
6.	elaiophylin
7.	quinone (benzoquinone)